BioSpace News Archive

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has appointed Vijaya Gadde to serve on its Board of Directors.

Magellan Health, Inc. (NASDAQ: MGLN) today announced it has appointed Caroline Carney, MD, MSc, FAPM, CPHQ, as chief medical officer of Magellan Health.

The BioCode® SARS-CoV-2 Assay is a CLIA high-complexity multiplex nucleic acid assay for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples including nasopharyngeal swabs, nasal swabs, oropharyngeal swabs and bronchoalveolar lavage from individuals who are suspected of COVID-19 by their healthcare provider

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2020 financial results on August 6, 2020 and members of its senior management team will host a conference call and webcast at 7:30am ET before the U.S. financial markets open.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced the grant of an inducement award to a new employee.

The Montreal Heart Institute (MHI) and Thermedical ® , a developer of thermal-ablation systems to treat ventricular arrhythmias, today announced the first ablation performed using the groundbreaking Durablate® retractable needle catheter and degassed saline, which together eliminate over 98% of the air bubbles that can lead to stroke. Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s

Walgreens, who has made major strides in recent years to improve product mix with natural alternatives, is once again leading the retailer pack with the introduction of EMUAIDMAX First Aid Ointment

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, will receive advisory services and up to $299,190 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRA

Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announced a five-year engagement with Cardinal Health, Inc., a global integrated healthcare services and products company, to provide a configuration of Inovalon’s ScriptMed® Cloud.

NLC Pharma has patented and developed 3C protease platform for SARS and other viruses 3C protease measures viral replication, as a rapid detection method for COVID Todos to develop At-Home Saliva test kit w/ digital analysis & software REHOVOT, Israel, and NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an in vitro diagnostics company focused on the distribution of a comprehensive suite of solutions for the screening and